Has Robert Liebross, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,600 in general payments to Robert Liebross, MD across 29 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Liebross, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Liebross, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Liebross, MD

Radiation Oncology · Indianapolis, INNPI 1598850653

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations.

$1,600in general payments, 2019–2025

Across 29 payments — averaging $55.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Viewray Technologies Inc$274
Varian Medical Systems, Inc.$235
Bioprotect Medical, Inc.$230
Siemens Medical Solutions USA, Inc.$188
Puma Biotechnology, Inc.$143
AstraZeneca$118
plus $413 from 11 others

What the payments were for

Food & beverage$1,600100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Viewray Technologies Inc	1	$274
Varian Medical Systems, Inc.	2	$235
Bioprotect Medical, Inc.	5	$230
Siemens Medical Solutions USA, Inc.	2	$188
Puma Biotechnology, Inc.	2	$143
AstraZeneca	1	$118
E.r. Squibb & Sons, L.L.C.	1	$110
Bayer	3	$44
Pharmacosmos Therapeutics Inc.	2	$41
Novartis	2	$37
Blue Earth Diagnostics	2	$32
Novocure Inc.	1	$31
Tempus AI, Inc	1	$29
GT Medical Technologies, Inc	1	$29
ADC Therapeutics America, Inc.	1	$24
Pfizer	1	$20
Sanofi	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,600 in reported general payments places this provider in the 70th percentile of 116 radiation oncology providers in Indiana.

See all radiation oncology providers in Indiana →

Medicare billing

Part B allowed, 2024

$174,250

Medicare patients

364

Services billed

2,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	40	$1,232
Dexamethasone	22	$625
Mometasone Furoate	37	$599
Tamsulosin Hcl	57	$554
Azelastine Hcl	19	$336
Levothyroxine Sodium	13	$174
Venlafaxine Hcl ErVenlafaxine Hcl	12	$144
Methylprednisolone	17	$115
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	14	$111
Ciprofloxacin Hcl	13	$81
Pantoprazole Sodium	11	$67
Omeprazole	14	$63
Lorazepam	17	$17
Diazepam	11	$16

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Indianapolis

Michael EatonIndianapolis$11K
Gordon WatsonIndianapolis$6K
John CoxIndianapolis$5K
Peter GarrettIndianapolis$5K
Garrett JensenIndianapolis$4K
Alexander YehIndianapolis$3K
Erin McCammackIndianapolis$2K
Zachary OaksIndianapolis$2K
David KimIndianapolis$2K
Darrel RossIndianapolis$2K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →